Recruiting OBSERVATIONAL NCT07452432
Korean Prospective Upper Tract Urothelial Carcinoma Cohort
Prospective Establishment of a Recurrence Monitoring Cohort in Korean Patients With Upper Tract Urothelial Carcinoma
Sponsor: Samsung Medical Center
Conditions
Urothelial Carcinoma (UC)
Interventions
Peripheral blood collection for ctDNA analysis
Updated 1 time since 2026 Last updated: Feb 28, 2026 Started: Jan 1, 2026 Primary completion: Jan 1, 2030 Completion: Jun 1, 2030
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
This observational or N/A phase trial investigates Urothelial Carcinoma (UC) and is currently actively recruiting participants. Samsung Medical Center leads this study, which shows 1 recorded version since 2026 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
1 version recorded Recruiting
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Samsung Medical Center
Data source: Samsung Medical Center
For direct contact, visit the study record on ClinicalTrials.gov .